The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 741 Metabolic Health articles
The GLP-1 receptor agonist market is experiencing explosive growth, transforming from a diabetes-focused treatment to a cornerstone of comprehensive metabolic care. Discover the key drivers, leading molecules like semaglutide and tirzepatide, and the future outlook.
Users of popular GLP-1 weight loss drugs are reporting a peculiar side effect: an intense new passion for perfumes, particularly sweet and gourmand scents. This phenomenon, nicknamed 'Ozempic smell,' is transforming wardrobes and wallets.
As 'Mounjaro brides' become a trend, an endocrinologist unpacks the medical realities, risks, and ethical concerns surrounding using powerful weight-loss medications for cosmetic pre-wedding transformations.
The soaring popularity and effectiveness of GLP-1 medications for weight loss are undeniably reshaping healthcare landscapes. But as demand surges, so do the costs, leading to significant implications for both employers and the individuals who rely on these treatments. This article delves into the financial pressures, employer strategies, and what you can expect regarding your co-pays and coverage for drugs like Ozempic, Wegovy, and Mounjaro.
Discover the natural power of MCT oil, a coconut derivative that's gaining attention for its potential to aid weight loss, boost energy, and enhance mental clarity. Learn how it works and if it's the right choice for you.
While GLP-1 agonists are revolutionizing weight management, emerging research suggests a potential downside: nutrient deficiencies. This article delves into what the latest studies reveal about these vital nutrient gaps and how to address them.
Many users of GLP-1 medications are reporting an unexpected and costly side effect: a profound fascination with perfume. This article delves into the phenomenon, exploring user experiences and expert theories.
The effectiveness of GLP-1 medications like Ozempic, Wegovy, and Mounjaro for weight loss has led to widespread adoption. However, a concerning trend is emerging: individuals with a history of or current eating disorders are increasingly turning to these drugs, raising alarm bells among healthcare professionals dedicated to eating disorder recovery.
The GLP-1 analogue market is experiencing unprecedented growth, transforming from diabetes treatments to comprehensive cardiometabolic solutions. Discover the key drivers, leading medications, and future innovations shaping this dynamic field.
